The manufacturer's in vivo study of 45 volunteers found 1% and 2.5% reduced the appearance of wrinkles by 7% and 12% respectively, after using it twice daily for 84 days
Effective July 1, health insurer Cigna (CI) will no longer cover GLP-1 weight-loss drugs such as Novo Nordisks (NVO) Wegovy and Eli Lillys (LLY) Zepbound in its employee health plan, Reuters reported, citing internal company communications
GLP-1 weight regain is common, but not inevitable
Cost varies by provider, formulation (methylcobalamin vs
This suggests that, for most individuals, taking these substances together may not pose significant risks
If stress is indeed contributing to your gray hairs, better stress management could help